Pfizer, Inc. (PFE)

Jim2B (43.62) Submitted: 8/22/06 1:29 AM : Start Price: $24.31 PFE Score: -19.58

The whole pharmaceutical industry has been oversold due to various concerns (e.g. recent NSAID lawsuits). However, these companies continue to rake in large amounts of cash. I don't think they'll stay out of favor for very long.

Report this Post Replies: 0 | Reply | Permalink

NoVaAmPro (97.99) Submitted: 12/04/06 10:23 AM : Start Price: $22.36 PFE Score: -5.59

Think Pfizer's going to be down for long? Please--this is big pharma, and the wealthiest areas of the world are graying quickly. Now's the time to go nutty on shares of the drug giant.

Report this Post Replies: 0 | Reply | Permalink

TMFHighYield (76.22) Submitted: 8/19/08 9:20 AM : Start Price: $19.90 PFE Score: -2.85

Chosen to be a part of the High Yield Portfolio strategy. Originally created by Fool UK's Stephen Bland (TMFPyad) in November 2000, the High-Yield Portfolio (HYP) strategy invests in a diversified group of 15 blue chip dividend-paying stocks with str...

Report this Post Replies: 1 | Reply | Permalink

austinbuck (< 20) Submitted: 9/22/06 4:21 AM : Start Price: $25.74 PFE Score: -22.62

Company is poised for a rebound. Still has solid financials, good pipeline of future products, and lots of cash cows that aren't going generic soon. New leadership will invigorate the company.

Report this Post Replies: 1 | Reply | Permalink

cyclepic (< 20) Submitted: 10/09/07 8:42 PM : Start Price: $24.11 PFE Score: 2.96

I have owned this so many times...pfizer has never performed well

Report this Post Replies: 1 | Reply | Permalink

healthcarevalue (98.81) Submitted: 5/25/07 4:10 PM : Start Price: $25.66 PFE Score: -9.75

Currrently, this stock is trading at 10.64 times trailing earnings. This is just way too low for a brand company like Pfizer, no matter what the circumstances, and it's striking. Very low debt/equity, at 0.102.

Report this Post Replies: 0 | Reply | Permalink

robert1schreiber (21.09) Submitted: 3/27/07 9:31 AM : Start Price: $23.68 PFE Score: 8.73

This organization pulled a potentialially valuable drug from the pipeline and has hurt their earnings potential. Furthermore, the money paid to the past President of Pfizer has caused a lot of folks to lose faith in the organization.

Report this Post Replies: 0 | Reply | Permalink

gainloss (53.90) Submitted: 12/04/06 10:36 AM : Start Price: $22.22 PFE Score: -5.12

Stock is worth $25 at 0% growth using cash flow as a metric. With an aging population to think that profits will not grow is quite bearish. After the 13% haircut today, PFE looks like a nice, fairly risky 2-5 year play to get you a 15-25% return.

Report this Post Replies: 0 | Reply | Permalink

danblanchard (< 20) Submitted: 1/08/08 9:52 PM : Start Price: $25.78 PFE Score: -21.46

They're going to buy someone soon. They can't keep growing buy laying off their sales force. Their pipeline is hurting for certain. Nothing going on that's too promising in Stage 3 trials. Look for a buy in the pain management sector.

Report this Post Replies: 0 | Reply | Permalink

fibreoptik (68.46) Submitted: 3/04/07 7:03 AM : Start Price: $22.86 PFE Score: -9.24

Long term biotech boom call on this one. Taking advantage of the current depression.

They have $5 billion left even after paying down all their debt (8B debt/13B cash) and their profit margins are 30%...

No reason I can think of to not buy and ho...

Report this Post Replies: 0 | Reply | Permalink